• Login
0 Items
Cannin - Cannabis & Hemp Investment Group
  • Home
  • Get Free Trial
  • Cannabis & Hemp News
  • Investment Resources
    • Featured Companies
    • Company Reports
    • Stock Quotes
    • Directory
  • Contact Us
  • Login
Select Page
Innocan Pharma Announces Filing of a Patent Application for Hair Loss Prevention

Innocan Pharma Announces Filing of a Patent Application for Hair Loss Prevention

Cannabis in the News, CBD in the News, CBD Stocks, Research, Science, Technology/Innovations

Innocan Pharma Announces Filing of a Patent Application for Hair Loss Prevention — Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – July 28, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the...
Clinical Study Shows Rare New Hemp Extract from ECS Brands Safely Promotes Weight Loss

Clinical Study Shows Rare New Hemp Extract from ECS Brands Safely Promotes Weight Loss

Cannabis in the News, CBD in the News, CBD Stocks, Hemp, Research, Science, Technology/Innovations

Human Clinical Study Shows Rare New Hemp Extract from ECS Brands Safely Promotes Weight Loss in 100 out of 100 Test Subjects – Without Changes to Diet or Exercise. Featuring natural ‘skinny cannabinoid’ THCV, Nitro-V Hemp Extract demonstrated...
MINDCURE Announces Filing of Provisional Patent for Company’s First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound

MINDCURE Announces Filing of Provisional Patent for Company’s First Fully Synthetic Routes to Create an Ibogaine Psychedelic Compound

Cannabis in the News, Psychedelic Stocks, Research, Science

The company’s pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug, ibogaine. MINDCURE Announces Filing of Provisional Patent for Company’s First Fully...
Innocan Pharma Files Patent Application for Topical Treatment for Diabetic Symptoms

Innocan Pharma Files Patent Application for Topical Treatment for Diabetic Symptoms

Cannabis in the News, CBD in the News, CBD Stocks, Extracts, International Cannabis News, Investment Opportunities, marijuana stock, Research, Science

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – July 9, 2021) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the “Company” or “Innocan”) announces the filing of an international patent application...
BioHarvest Sciences Inc. Shareholder Update

BioHarvest Sciences Inc. Shareholder Update

Cannabis in the News, Financial Results, marijuana stock, Research, Science

BioHarvest Sciences Inc. Shareholder Update — Vancouver, British Columbia–(Newsfile Corp. – July 2, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (the “Company”, “BioHarvest”) invites its shareholders and the general...
5 Things to Know Before Buying Delta-8

5 Things to Know Before Buying Delta-8

Cannabis in the News, CBD in the News, Hemp, Research, Safety, Science

5 things you should know before trying Delta-8 THC for the first time. Be safe before you do. NASHVILLE, Ark., June 28, 2021 /PRNewswire/ — Ivan Green, Editor of The Cannabis Radar, Nashville’s very own award-winning cannabis journalist, wrote a blog post...
« Older Entries

Login

 
 
Forgot Password

Search Cannabis and Hemp Stocks

https://aphrihelios.com/

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Recent Posts

  • Innocan Pharma Announces Filing of a Patent Application for Hair Loss Prevention July 28, 2021
  • Global Cannabidiol Market Size Expected to Reach $2.8 Billion by 2028 July 28, 2021
  • RocketFuel Introduces Crypto Payment Solution for Cannabis July 28, 2021
  • Tilray Reports 2021 Fiscal Year and Q4 Results July 28, 2021
  • Should You Invest in AphriHelios? July 28, 2021
Best Cannabis Stocks 2021

Cannabis Stock Watchlist

×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
×
Key metrics
Market Cap
PE Ratio
PEG Ratio
EPS
Beta
Dividends
Dividend Rate
Dividend Yield
Ex Dividend Date
50 Days Moving Average
200 Days Moving Average
Key data
Symbol
Name
Bid
Ask
Last Price
Change
52 Week Low
52 Week High
Symbol Last Price % Change

Search for Specific Hemp and Cannabis Stocks

From the Cannin Community

"Cannin sends specific instructions on how to make the trade. They continue to send profitable signals and I love their service. Thanks, Cannin!"

-Mark H.
Vail, Colorado

https://aphrihelios.com/

Cannin Monthly Subscription with Trading Alerts

Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.

GET A FREE TRIAL

$99 / month after 30-day trial. Still unsure? Schedule demo at demo@cannin.com or call 720-254-1374

Cannin’s Track Record

Best Hemp Stocks 2021 - Cannin Report

The Best Cannabis Stocks for 2021

  • Cannin Report Q1 2021 Cannin Report Q2 2021 $99.00 $49.00
  • Cannin Report Q1 2021 Cannin Report Q1 2021 - Planet 13 Holdings $19.00 $4.99
  • Cannin Report Q1 2021 Cannin Report Q1 2021 - Innovative Industrial Properties $19.00 $4.99
  • Cannin Report Q1 2021 Cannin Report Q1 2021 $99.00 $49.00
  • The Cannin Report 2020 $49.00 $19.00

Free Cannabis News & Investment Tips

Delivered to your inbox, Every Sunday

Risk of Prosecution for Marijuana-Related Companies.  If you are considering investing in a company that is connected to the marijuana industry, be aware that marijuana-related companies may be at risk of federal, and perhaps state, criminal prosecution.  The Department of Treasury recently issued guidance noting: “ The Controlled Substances Act (“CSA”) makes it illegal under federal law to manufacture, distribute, or dispense marijuana.  Many states impose and enforce similar prohibitions.  Notwithstanding the federal ban, as of the date of this guidance, 20 states and the District of Columbia have legalized certain marijuana-related activity.”

  • Facebook
  • Twitter
  • Instagram
© 2020 Cannin All Rights Reserved. | Refund | Terms | Privacy | Cannin.com 3000 Lawrence Street #6 Denver, Colorado 80205
Terms:
First Week Free, then $39/month. Cancel Anytime.
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above
Terms:
First Week FREE then $99/month. Cancel Anytime.
Invalid Username
Invalid Email
Invalid Password
Password Confirmation Doesn't Match
Have a coupon?
Loading... Invalid Coupon
Authorize.net
Invalid Credit Card Number
Invalid Expiration
Invalid CVC Code
 
Loading... Please fix the errors above